drug interaction(s) of renin-angiotensin-aldosterone inhibitors with SGLT-2 inhibitor
Jump to navigation
Jump to search
Drug interactions
- initiation of SGLT-2 inhibitor reduces risk of hyperkalemia among patients using ACE inhhibitor or ARB to manage diabetes, heart failure, or chronic kidney disease
More general terms
References
- ↑ Wing S, Ray JG, Yau K et al SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors. JAMA Intern Med. 2025 Apr 28:e250686. PMID: https://pubmed.ncbi.nlm.nih.gov/40293730 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2833308